Since the popularization of fat grafting by Syd Coleman 1 in the last decade of the last century, a variety of techniques for fat harvesting, preparation, and injection have been proposed. As the authors correctly state, these multiple processing and handling methods lead to variations in graft retention and viability, resulting in unpredictable clinical outcomes.
Since the popularization of fat grafting by Syd Coleman 1 in the last decade of the last century, a variety of techniques for fat harvesting, preparation, and injection have been proposed. As the authors correctly state, these multiple processing and handling methods lead to variations in graft retention and viability, resulting in unpredictable clinical outcomes. 2 They also argue that the underlying molecular mechanisms belying the varying fat grafting processes are not well understood. 2 Since the discovery by Zuk 3 in 2002 that human adipose tissue is a rich source of multipotent stem cells, the adipose derived stem cell (ADSC) became so hyped that some surgeons now even talk about "stemcell facelifts"-all this without much evidence.
The authors must be congratulated with their simple but very clever experimental setup. They processed lipoaspirates into emulsified fat and isolated stromal vascular fraction (SVF) and free lipids (adipocyte fractions) by centrifugation. They enriched the SVF with 0%, 5%, 10%, and 15% free lipid and injected these under the panniculus carnosus along the dorsum of athymic rats. Forty-five days later, they saw that SVF with 10% free lipid showed the best adipocyte architecture with rich collagen and elastin network. Also, the CD44 staining demonstrated a higher inflammatory response in the 10% free-lipid group. Their study suggests that free lipids provide a milieu for enhancing cell viability and stem cell differentiation into adipocytes and other cells. On top of that, their study also implies that the free lipids stimulate inflammation of the fat graft and increase collagen and elastin production.
To our knowledge, this is the first time that the importance of the oily fraction of the fat grafting specimen has been so clearly and simply demonstrated. The article also reminds us how little we know about the fundamental mechanisms of fat grafting, and the effects of SVF grafting on skin rejuvenation. A lot of unanswered questions still remain: what is the role of inflammation in the fat grafting process? What is the role of the extracellular matrix (ECM) in the fat grafting process? Is fat grafting with the purpose of volume augmentation, such as breast or buttocks augmentation, the same as fat grafting with the purpose of skin rejuvenation, such as in the face, neck, décolleté, and hands? Does injected fat behave the same in the subcutaneous level as in the intradermal level? What is the role of ADSC in the fat grafting process? What is the role of signaling factors between mechanically traumatized adipocytes by, for instance, exosomes in the fat grafting and/ or regeneration process?
Isolation of the stromal vascular fraction is typically done by enzymatic digestion of the collagen matrix and has been proven to be time consuming, complicated, and nowadays virtually impossible in most countries, due to regulation issues of bioactive medication. In 2013, we described a technique to concentrate the SVF trough mechanical dissociation of the microfat lipoaspirate tissue by means of a simple emulsification process. 3 This product was called nanofat, pointing out that we mechanically destroyed the larger adipocytes and were left over with a mixture of smaller cells from the fat's stromal vascular fraction, which appeared to be viable. We injected this whole liquid mixture very superficially in the skin for all kinds of skin aging problems and saw remarkable clinical results, especially on pigment-related skin conditions such as a dark circle of the lower eyelid and sun-damaged neck and décolleté skin (Figures 1 and 2 ). When injecting nanofat into the skin, we noticed a degree of inflammation in the nanofat treated areas. Some colleagues suggested that the oily fraction of the nanofat may be responsible for this inflammation, and that it should be removed via centrifugation. However, the clinical results convinced us not to change our protocol. Our hypothesis that injecting the whole mixture of cells, intracellular proteins, cytokines, hormones, and extracellular matrix was based on the assumption that it is important to preserve the intercellular cross-talk and signaling functions present in the nanofat mixture. In our research, we found that although the adipocytes were not viable, there was a proven viability of ADSC, and these emulsified cells kept their potential to differentiate into an adipogenic lineage. The authors refer to our article, 4 saying that we suggested that stem cells are solely responsible for skin rejuvenation. In fact, we never suggested this. We proved that stem cells were still viable after the emulsification process, but we were and still are very ignorant about the mechanisms resulting in the obtained clinical results. In recent years, a variety of clinical and research articles were published that confirmed the regenerative capacities and indications of nanofat. [5] [6] [7] [8] [9] [10] Nanofat preparation is a multiple-step procedure, which can be executed in many variations. Many authors have introduced small variations in the preparation technique, mostly based on personal preferences, with little or no scientific basis. In our 6 years of clinical experience with nanofat, we still stick to the general principles of nanofat preparation but made one small but important change to the nanofat emulsification protocol. Before, we used to emulsify 30 times with a wide 2.5 mm leur to luer lock emulsifier. Occasionally we encountered a few cases of visible fat deposition under the skin, suggesting that our emulsification was not done thoroughly enough and that we did not destroy all the adipocytes. Especially under the delicate eyelid skin, this was very bothersome. Three years ago, we changed our emulsification protocol into a progressive sequential emulsification, first by a 2.4 mm emulsifier, followed by a narrower 1.2 mm emulsifier (Tulip Medical Products, San Diego, CA, USA). After this double emulsification, we have virtually destroyed all the adipocytes and never saw the fat deposition under the skin anymore. The use of the 1.2 mm emulsifier alone was often not possible due to the high fibrosity of the microfat, making the laminar flow during the emulsification process impossible (Video 1).
One year ago, we started performing nanofat needling with a special needling device ("Hydra Needle 20, Guangzhou Ekai electronic Technology Co, Guangzhou, China). We think we can provide a more even depth of distribution of nanofat in the skin and that this method combines the advantage of needling with the nanofat concept (Video 2).
In summary, the authors proved that the presence of free lipids is important for the transformation of SVF into adipocytes and non-adipose cells. This may be an important factor in the improvement of fat graft viability and ECM production and may play a role in the clinical changes seen in improvement of skin quality in atrophic scars and sun-damaged skin. They have confirmed that micronized fat grafts obtained by simple mechanical emulsification may be a very interesting tool to regenerate the skin and helped us to obtain a scientifically based protocol for the most active mixture of SVF and free lipids. We would like to congratulate the authors for their potentially very important contribution to the deeper understanding of the mechanisms of fat grafting and tissue regeneration.
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